Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia

Leukemia

Volumn 12, Issue 12, 1998, Pages 2024-2028

  Bolufer, P ^a   Barragan E ^a   Sanz M A ^a   Martin G ^a   Bornstein, R ^b   Colomer, D ^c   Delgado, M D ^d   Gonzalez M ^e   Marugan, I ^f   Roman J ^g   Gomez M T ^h   Anguita, E ⁱ   Diverio, D ^j   Chomienne, Ch ^k   Briz, M ^l  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Area Biología Molecular   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h Laboratory of Molecular Biology   (Spain)

ⁱ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k SAINT LOUIS HOSPITAL   (France)

^l Depto de Biol Molec Pharma Gen SA   (Spain)

more..

Author keywords

Acute promyelocytic leukemia; External quality assessment; PML RAR rearrangement; RT PCR

Indexed keywords

COMPLEMENTARY DNA; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER GENETICS; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17344370602     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401225     Document Type: Article

References (10)

1. Cuppens H, Cassiman JJ. A quality control study of CFTR mutation screening in 40 different European laboratories. The European Concerted Action on Cystic Fibrosis. Eur J Hum Genet 1995; 3: 235-245.
2. Grundy JE, Ehrnst A, Einsele H, Emery VC, Hebart H, Prentice HG, Ljungman P. A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood. J Clin Microbiol 1996; 34: 1166-1170.
3. Guy EC, Pelloux H, Lappalainen M, Aspöck H, Hassl A, Melby KK, Holdberg-Pettersen M, Pettersen E, Simon J, Ambroise-Thomas P. Interlaboratory comparison of polymerase chain reaction for detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis 1996; 15: 836-839.
4. Reichelderfer PS, Jackson JB. Quality assurance and use of PCR in clinical trials. PCR Meth Appl 1994; 4: S141-S149.
5. Winters MA, Tan LB, Katzenstein DA, Merigan TC. Biological variation and quality control of plasma immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J Clin Microbiol 1993; 31: 2960-2966.
6. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelici PG. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437-1438.
7. Biondi A, Ramboldi A, Pandolfi PP, Rosi V, Giudici G, Alcalay M, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PC. Molecular monitoring of the myl/retinoic acid receptor α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492-497.
8. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T, Dube I, Windfield DA, Kingston J, Hagemaijer A, Rees JK, Lister TA, Solomon E. Diagnosis of acute promyelocytic leukemia by RT-PCR detection of PML-RARα and RARα-PML fusion transcripts. Br J Haematol 1992; 82: 529-540.
9. Huang W, Sun GL, Li XS, Cao LQ, Jang GS, Zahn FQ, Chai JR, Wang Z, Waxman S, Chen Z, Chen SJ. Acute promyelocytic leukemia: clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/ polymerase chain reaction to predict relapse. Blood 1993; 82: 1264-1269.
10. Castaigne S, Balitrand N, De The H, Dejean A, Degos L, Chomienne C. A PML/retinoic acid receptor a fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110-3115.